Prognostic relevance of a scoring system based on clinical and biological parameters in early chronic lymphocytic leukemia

Hematology Journal

Volumn 1, Issue 5, 2000, Pages 301-306

  Leotard, S ^a   Chastang, C ^b   Travade, P ^c   Jaudon, M C ^a   Tournilhac, O ^c   Baudet, S ^a   Merle Beral, H ^a,d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔTEL DIEU   (France)

^d BICHAT HOSPITAL   (France)

Author keywords

B CLL stage A; Scoring system; Serological parameters; Soluble CD23

Indexed keywords

BETA 2 MICROGLOBULIN; IMMUNOGLOBULIN E RECEPTOR; LACTATE DEHYDROGENASE; SERUM ALBUMIN;

ADULT; AGAMMAGLOBULINEMIA; AGED; ANALYSIS OF VARIANCE; ARTICLE; B CELL LEUKEMIA; BLOOD; CANCER STAGING; CLASSIFICATION; COMPARATIVE STUDY; DISEASE COURSE; EVALUATION; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LIVER; LYMPH NODE; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; SPLEEN;

ADULT; AGAMMAGLOBULINEMIA; AGED; ANALYSIS OF VARIANCE; BETA 2-MICROGLOBULIN; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; L-LACTATE DEHYDROGENASE; LEUKEMIA, B-CELL, CHRONIC; LIVER; LYMPH NODES; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RECEPTORS, IGE; RETROSPECTIVE STUDIES; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; SPLEEN;

EID: 0034585153     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200055     Document Type: Article

References (38)

1. Rai KR, Sawiwtsky A, Cronkite EP, Chanana AB, Levy RN, Pasternack BS. Clinical staging of chronic leukemia. Blood 46: 219, 1975.
2. Binet J-L, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Montconduit M, Belabbes S, Grmy F. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48: 198, 1981.
3. Dighiero G, Maloum K, Desablens B, Cazin B, Navarro M, Leblay R, Leporrier M, Jaubert J, Lepeu G, Dreyfus B, Binet J-L, Travade P. Chlorambucil in indolent chronic lymphocytic leukemia. The New England Journal of Medicine 338: 1506, 1998.
4. Jaksic B, Vitale B. Total mass score (TTM): a new parameter in chronic lymphocytic leukemia. British Journal of Haematology 49: 405, 1981.
5. Rozman C, Montserrat E, Fernandez-Ranada J. Bone marrow histologic pattern. The best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood 64: 642, 1984.
6. Montserrat E, Sanchez-Bisono J, Vinolas N, Rozman C. Lymphocyte doubling time in chronic lymphocytic leukemia: analysis of its prognostic significance. British Journal of Haematology 62: 567, 1986.
7. Molica S, Alberti A. Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia. Cancer 60: 2712, 1987.
8. Simonsson B, Wibell L, Nilsson. β2 microglobuline in chronic lymphocytic leukemia. Scand Journal of Haematology 24: 174, 1980.
9. Keating MJ, Lerner S, Kantarjian H. The serum β2 microglobuline level is more powerful than stage in predicting response and survival in chronic lymphocytic leukemia. Blood 86 (suppl 1): 60a, 1995.
10. Halleck M, Wanders L, Emmerich B. Serum β2 microglobuline and serum thymidine kinase are independent predictor of progression free survival in chronic lymphocytic leukemia. Leukemia and Lymphoma 22: 439, 1996.
11. Källender C, Simonsson B, Hagberg B, Gronowitz J. Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia. Cancer 54: 2450, 1984.
12. Merle-Béral H, Blanc C, Chastang C, Debré P. Phenotypic heterogeneity of B-and T-cell differentiation antigens in B-CLL. European Journal of Haemotology 41: 197, 1988.
13. Orfao A, Gonzalez M, San Miguel JF, Rios A, Canizo MC, Hernandez J, Maricato ML, Lopez Borrasca A. B-cell chronic lymphocytic leukaemia: prognostic value of the immunophenotype and the clinico-hematological features. American Journal of Hematology 31: 26, 1989.
14. Geisler CH, Larsen JK, Hansen NE, Hansen MM, Christensen BE, Lund B, Nielsen H, Plestner T, Thorling K, Andersen E. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 78: 1795, 1991.
15. Kurec AS, Threatte GA, Gottlieb AJ, Smith JR, Anderson J, Davey FR. Immunophenotypic subclassification of chronic lymphocytic leukaemia (CLL). British Journal of Haematology 81: 45, 1992.
16. Robertson Le, Plunkett W, McConnell K. Bcl2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. Leukemia 10: 456, 1996.
17. Gardiner AC, Corcoran MM, Oscier DG. Cytogenetic, Fluorescence in situ hybridisation, and clinical evaluation of translocations with concomitant deletion at 13q14 in chronic lymphocytic leukaemia. Genes Chromosomes & Cancer 20: 73, 1997.
18. Döhner H, Stilgenbauer S, Döhner K, Bentz M, Lichter P. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. Journal of Molecular Medicine 77: 266, 1999.
19. Vhrovac R, Delmer A, Tang R, Marie J-P, Zittoun R, Ajchenbaum-Cymbalista F. Prognostic significance of the cell cycle inhibitor p27KIP1 in chronic B-cell lymphocytic leukemia. Blood 91: 4694, 1998.
20. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94: 1840, 1999.
21. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94: 1848, 1999.
22. Sarfati M, Chevret S, Chastang C, Biron G, Stryckman P, Delespesse G, Binet J-L, Merle-Béral H, Bron D. Prognostic importance of serum solubles CD23 level in chronic lymphocytic leukemia. Blood 88: 4259, 1996.
23. Beguin Y, Lampertz S, De Groote D, Igot D, Malaise M, Fillet G. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia. Leukemia 7: 2019, 1993.
24. Reinisch W, Wilheim M, Hilgarth M, Gasche C, Mader R, Spezfalusi S, Steger G, Berger R, Lechner K, Boltz-Nitulescu G, Schwazmeier JD. Soluble CD23 reliably reflects disease activity in B cell chronic lymphocytic leukemia. Journal Clinical of Oncology 12, 2146, 1994.
25. Vinante F, Vassanelli A, Zanotti R, Nadali G, Krampera M, Morosato L, Chilosi M, Pizzolo G. Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B cell chronic lymphoproliferative disorders. International Journal of Clinical Laboratory Research 25: 189, 1995.
26. Dine G, Culioli B, Rehin Y, Brahimi. Soluble CD23 a tumoral indicator of B CLL. American Society of Hematology, Abstract, 1995.
27. Molica S, Levato D, Dell'Olio. Cellular expression and circulating levels of soluble CD23 in B cell chronic lymphocytic leukemia. Implications for prognosis. Haematologica 81: 428, 1996.
28. Knauf WU, Langenmayer I, Ehlers B, Mohr B, Adorf D, Nerl CH, Hallek M, Zwingers TH, Emmerich B, Thiel E. Serum levels of soluble CD23, but not soluble CD25 predict disease progression in early stage B cell chronic lymphocytic leukemia. Leukemia and Lymphoma 27: 523, 1997.
29. Desablens B, Capiod JC, Gouilleux V, Garidi R, Lamour C, Prin L. sCD23, sCD25, serum LDH and β2 microglobuline. What is the best prognostic factor in B CLL? Analysis of 109 patients. Abstract Book VII International Workshop on CLL, Crete, 2-4 May, 82: 1997.
30. Shvidel L, Hofstein R, Berrebi A. Serum β2 microglobuline as a marker of B cell in chronic lymphoid malignancies. American Journal of Hematology 53: 148, 1996. (Letter)
31. O'Brien S, Kantarjian H, Beran M, Smith T, Koller C, Estey E, Robertson LE, Lerner S, Keating M. Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment. Blood 82: 1695, 1993.
32. Rambotti P, Davis S. Lactate deshydrogenase in normal and leukemic lymphocyte subpopulations: evidence for the presence of abnormal T cells and B cells in chronic lymphocytic leukemia. Blood 57: 324, 1981.
33. Desablens B, Garidi R, Lamour C. Prognostic value of LDH and β2 microglobuline in B CLL. Analysis of 275 patients. Abstract Book VII International Workshop on CLL, Crete, 2-4 May, 81a, 1997.
34. 2-microglobulin in B-cell chronic lymphocytic leukemia. European Journal of Haematology 62: 117, 1999.
35. Rozman C, Montserrat E. Chronic lymphocytic leukemia. The New England Journal of Medicine 333: 1052, 1995.
36. Orfao A, Gonzalez M, San Miguel JF, Rios A, Canizo MC, Hernandez J, Maricato ML, Lopez Borrasca A. B-cell chronic lymphocytic leukaemia: prognostic value of the immunophenotype and the clinico-haematological features. American Journal of Hematology 31: 26, 1989.
37. Lee JS, Dixon DO, Kantarjian HM, Keating MJ, Talpaz M. Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients. Blood, 69: 929, 1987.
38. Fiddes P, Pemy R, Wells UJ, Rosenberg MC. Clinical correlation with immunoglobulin levels in chronic lymphocytic leukemia. Australia and New Zealand Journal of Medicine 4: 346, 1972.